Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre
CovidImmunEye
Immune Status: Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Sample of the Eye Department (University Eye Hospital and Research Institute Tübingen)
1 other identifier
observational
300
1 country
1
Brief Summary
A sequential combination of different antibodies test against SARS-CoV-2 is evaluated. The protocol included a rapid test and several ELISA tests within a defined cohort of healthcare workers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 13, 2020
CompletedFirst Submitted
Initial submission to the registry
June 22, 2020
CompletedFirst Posted
Study publicly available on registry
June 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedJune 24, 2020
May 1, 2020
2 months
June 22, 2020
June 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Seroprevalence
Rate of anti-SARS-CoV-2 Antibodies
through study completion, maximum of one year
Secondary Outcomes (2)
Agreement of the test results and questionnaire
through study completion, maximum of one year
Positive predictive / negative values of the tests applied
through study completion, maximum of one year
Study Arms (1)
Healthcare Worker
Staff of the Department of Ophthalmology, University Tuebingen, Germany
Interventions
Eligibility Criteria
Employee of the Department of Ophthalmology (at a university institution)
You may qualify if:
- Employees of the health facility described
- voluntary request for testing
You may not qualify if:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Tuebingen
Tübingen, Baden-Wurttemberg, 72076, Germany
Biospecimen
Blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2020
First Posted
June 24, 2020
Study Start
May 13, 2020
Primary Completion
June 30, 2020
Study Completion
August 1, 2020
Last Updated
June 24, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share